STAGE I BREAST CANCER AJCC V7

This phase II trial is testing a type of radiation called proton beam therapy for women with early-stage breast cancer (stage 0 to II). The goal is to see if this targeted approach can kill cancer cells while causing less damage to normal tissue, leading to fewer side effects and…

This study tests a type of radiation called hypofractionated partial breast irradiation for women with early-stage breast cancer. Instead of treating the whole breast, it targets only the area where the cancer was removed, using higher doses over fewer sessions. The goal is to se…

This early-phase trial is testing whether a gel form of the drug endoxifen can be safely applied to the skin in women scheduled for breast surgery. The study includes 32 women with various stages of breast cancer or high genetic risk. Researchers are checking for skin reactions a…

This study tests whether adding the immunotherapy drug pembrolizumab after standard chemotherapy helps prevent breast cancer from returning in people with triple-negative breast cancer. About 1,155 participants who still had cancer after chemo will receive either pembrolizumab or…

This phase 2 trial tests whether electroacupuncture can reduce chronic pain in women who have completed treatment for stage I-III breast cancer. 111 participants will receive either real acupuncture, sham acupuncture, or no treatment. The goal is to see if this gentle needle ther…

This study compares a 3-week course of radiation to the standard 5-week course for breast cancer patients who need radiation to the lymph nodes. The goal is to see if the shorter schedule is just as effective at preventing cancer from coming back, while causing less arm swelling …